(Q40556021)
Statements
1 reference
Phase I trial of concurrent twice-weekly recombinant human interleukin-12 plus low-dose IL-2 in patients with melanoma or renal cell carcinoma (English)
1 reference
Jared A Gollob
1 reference
Korina G Veenstra
1 reference
Robert A Parker
1 reference
James W Mier
1 reference
David F McDermott
1 reference
Daniel Clancy
1 reference
Linda Tutin
1 reference
Henry Koon
1 reference
Michael B Atkins
1 reference
1 July 2003
1 reference
1 reference
21
1 reference
13
1 reference
2564-2573
1 reference
Identifiers
1 reference
1 reference